Neuroinflammation in Alzheimer's disease continuum

Aging population brings an ever-increasing global burden of dementia, and Alzheimer's disease (AD) is the most frequent type worldwide. Many years of research have introduced characteristic cerebral histopathological and molecular changes in this disease. However, all attempts to establish an e...

Full description

Bibliographic Details
Main Authors: Aslihan Taskiran-Sag, Müge Yemişçi
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:Neurological Sciences and Neurophysiology
Subjects:
Online Access:http://www.nsnjournal.org/article.asp?issn=2636-865X;year=2020;volume=37;issue=4;spage=155;epage=163;aulast=Taskiran-Sag
Description
Summary:Aging population brings an ever-increasing global burden of dementia, and Alzheimer's disease (AD) is the most frequent type worldwide. Many years of research have introduced characteristic cerebral histopathological and molecular changes in this disease. However, all attempts to establish an effective treatment have failed. In this review, we aim to address the basic evidence regarding the role of inflammatory mediators in AD and their link to the other pathogenetic pathways. Novel findings based on advanced biotechnology and bioinformatics are covered briefly, as well.
ISSN:2636-865X